Page 7 - Refactor Capital News Today

April 29, 2021 April 29, 2021 | Illumina joins the Gates Foundation in a global pathogen genomics initiative, new money for immune profiling, and Benchling nets $200M for their cloud platform.   $375M: Fund for Growth-Stage Medtech, Digital Health  Endeavour Vision has closed Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations th...

Temasek Invests in Solugen to Boost Asia Opportunities Posted on 04/27/2021 Formed in 2016 by Gaurab Chakrabarti, M.D., Ph.D., and Sean Hunt, Ph.D., Solugen Inc. is a synthetic biology chemicals manufacturer. Singapore’s Temasek Holdings made an investment in Solugen to support further scaleup and sales growth of Solugen’s molecular manufacturing platform that harnesses biology to make high-performing, cost effective carbon negative chemicals, ingredients, and materials. Solugen believes So...

Ophelia, a NYC-based healthcare tech startup providing treatment for Opioid Use Disorder (OUD), raised $15m in Series A funding. The round was led by Menlo Ventures with participation from Y Combinator, General Catalyst, Refactor Capital, and the founders of Flatiron Health, Warby Parker, Harry’s, Allbirds, PillPack, Carbon Health, and Lambda School. The company intends to use the funds to continue to build and expand its services to patients across the U.S., to soon accept insurance, inclu...

Mori, a Boston, MA-based food technology company, raised $16m in Series B financing. The round was led by the Drawdown Fund with participation from previous investors Acre Venture Partners, The Engine, Prelude Ventures, Refactor Capital, Closed Loop Partners as well as new investor Knollwood Investment Advisory. The company intends to use the funds to accelerate commercialization into numerous categories and geographies, while expanding its product development pipeline. Led by Adam Behr...

(Image: "1 US Bank Note"/geralt via Pixabay, licensed under Creative Commons Zero) A new digital companion application helping families navigate the logistical and emotional journey of losing a loved one launched this week with $13 million in seed funding. Called Empathy, the company is backed by the round’s leading investors General Catalyst and Aleph. Empathy’s platform leads grieving families through end-of-life bureaucratic tasks such as arranging a funeral, validating a will, canceling...

AlleyWatch Gencove New York-based Gencove’s low-pass sequencing platforms delivers whole genome discovery at the cost of genotyping arrays. Founded by Joe Pickrell, Kaja Wasik, and Tomaz Berisa in 2015, Gencove is backed by investors that include Alexandria Venture Investments, Balaji Srinivasan, Refactor Capital, SV Angel, and Version One Ventures. FOUNDED:2015 FOUNDERS:Joe Pickrell, Kaja Wasik, Tomaz Berisa